Surzen Biotherapeutics
PrivateLast Round
Grant
Aug 1, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Surzen Biotherapeutics operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Grant round in August 2026.
Surzen Biotherapeutics is a biotechnology company developing peptide therapeutics designed to enhance the effectiveness of opioid analgesics while reducing associated complications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Surzen Biotherapeutics Comparables
Compare Surzen Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mimetic Medicines | 74% |
For institutional investors. Book with your work email.
Surzen Biotherapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Surzen Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Saisei Ventures | Seed |
| Okinawa Prefectural Government | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Received grant funding from the Okinawa Prefectural Government.
For institutional investors. Book with your work email.
Surzen Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Surzen Biotherapeutics's valuation, stock price, and market status.
Is Surzen Biotherapeutics a public or private company?
Surzen Biotherapeutics is a private company.
What is the current stock price of Surzen Biotherapeutics?
Surzen Biotherapeutics is a private company, so its shares have no public market price. Caplight tracks Surzen Biotherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Surzen Biotherapeutics worth (valuation)?
Valuation information for Surzen Biotherapeutics is not publicly available.
Can I buy Surzen Biotherapeutics stock?
Surzen Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Surzen Biotherapeutics's last funding round?
Surzen Biotherapeutics's most recent funding round was Grant on August 1, 2026.
Who are the main investors in Surzen Biotherapeutics?
Key investors in Surzen Biotherapeutics include Saisei Ventures.
Will Surzen Biotherapeutics IPO soon?
No public IPO plans have been announced for Surzen Biotherapeutics.
How can I track Surzen Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Surzen Biotherapeutics's shares on secondary markets.